Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.
01:11:17 min
CLEAR ALL
REBUS and the Anarchic Brain: A Unified Model of the Brain Action of Psychedelics Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University.
1
Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.
Robert Jesse will offer a view, spanning the decade from the birth of Horizons to the present day, of the significant developments that have occurred in several areas of our field. Surely they amount to a re-emergence of psychedelics. People speak of a renaissance.
Robert Jesse is the organiser of the Council on Spiritual Practices, which aims to shift modernity's awareness and practices with respect to primary religious experience.
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.
Natalie Ginsberg, MSW, discusses ayahuasca and the healing potential of psychedelics for intergenerational trauma in the Palestinian-Israeli conflict.
In this timely webinar - moderated by Chief Psychologist (USA) Dr. Dominique Morisano - clinical psychologist and thought-leader Dr.
Ketamine is a controversial yet effective treatment in psychiatry, and it arrives at a much needed time as depression and suicide rates have reached crisis levels in the United States.
Here he describes the process of setting up a program to research the psychedelic drug, DMT, at the University of New Mexico. It took two years to obtain the required permissions, as there had been a twenty year hiatus in psychedelic research on human subjects.
A small community of experimental psychotherapists—along with self-medicating users—have been using acid and mushrooms to treat mental health conditions for years, with promising results.